Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed

NCT01619566 ↗

Phase 4 Withdrawn University of California, San Diego

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Subjects with Fibromyalgia who respond to Duloxetine have specific nerve fiber characteristics. This can be used to predict which future patients will respond to Duloxetine.

Timeline

Start: 2012-06
Primary completion: 2015-01
Completion: 2015-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Duloxetine	Small molecule	60 mg	Oral

Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed

Summary

Timeline

Drugs

Indications